3
Published 2020
Canadian Agency for Drugs and Technologies in Health
... of induction therapy, while the clinical criteria for the plaque psoriasis indication were: greater than 10...

4
Published 2020
Canadian Agency for Drugs and Technologies in Health
... with moderately to severely active ulcerative colitis who have failed or were intolerant to treatment...

5
Published 2020
CADTH
... to severely active ulcerative colitis who have had an inadequate response to, loss of response to, or were...

6
Published 2020
Canadian Agency for Drugs and Technologies in Health
... who have had an inadequate response or loss of response to, or who were intolerant to either...

7
Published 2020
Canadian Agency for Drugs and Technologies in Health
... who have had an inadequate response or loss of response to, or who were intolerant to either...

8
Published 2013
Canadian Agency for Drugs and Technologies in Health
...Since the original CADTH reports were published, interest has emerged in the combined use...

9
Published 2013
Canadian Agency for Drugs and Technologies in Health
...Since the original CADTH reports were published, interest has emerged in the combined use...

10
Published 2012
Canadian Agency for Drugs and Technologies in Health
...Since the original CADTH reports were published, interest has emerged in the combined use...

11
Published 2012
Canadian Agency for Drugs and Technologies in Health
...Since the original CADTH reports were published, interest has emerged in the combined use...

12
Published 2020
Canadian Agency for Drugs and Technologies in Health
...Health-state utilities were further adjusted by treatment-specific time-dependent utilities based...

13
Published 2013
Canadian Agency for Drugs and Technologies in Health
..., were unsuccessfully resuscitated, or critically ill patients who experienced unexpected cardiac arrest...

14
Published 2020
Canadian Agency for Drugs and Technologies in Health
...Health-state utilities were further adjusted by treatment-specific time-dependent utilities based...

15
Published 2017
Canadian Agency for Drugs and Technologies in Health
.... In addition, three concomitant events were incorporated to capture complications related to VTE: chronic...

16
Published 2017
Canadian Agency for Drugs and Technologies in Health
.... In addition, three concomitant events were incorporated to capture complications related to VTE: chronic...

17
Published 2020
CADTH
... for first-line treatment and short- and long-term AEs were assumed to occur over the first two-month cycle...

20
Published 2021
Canadian Agency for Drugs and Technologies in Health
... of the SMN2 gene who were pre-symptomatic at baseline, but limitations within the clinical data informing...